Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04463498

Sleep in Psychiatric Care (SIP): A Transdiagnostic Group-based Sleep-school as Treatment for Comorbid Insomnia

Sleep disorders commonly co-occur with psychiatric disorders. Sleep disorders are often treated with medication or not at all in psychiatric care, although there exist a plethora of documentation of the effectiveness of sleep interventions. There is also an increase in studies showing effectiveness of sleep-interventions when the sleep disorder co-occurs with psychiatric illness. The most common and best documented treatment for insomnia is cognitive behavioral therapy for insomnia (CBTi). There is a great gap in the knowledge on how sleep disorders can be treated effectively in psychiatric care. In this project the investigators therefore seek to investigate the effect of non-pharmacological, group-based treatment in a randomized controlled trial (RCT) where sleep and psychiatric symptoms are the primary outcome measures. CBTi comprise of sleep education, sleep restriction, stimulus control and cognitive restructuring of dysfunctional thoughts about sleep.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

The recommended treatment for insomnia is CBTi. Recent research has proven that dark therapy, or blocking light in wavelengths <530 nm by the use of for example orange blue-blocking glasses (bb-glasses), has shown the ability to maintain melatonin production comparable to darkness and to have an additive effect in the treatment of insomnia. The investigators therefore also want to test bb-glasses as an additive treatment to CBTi for insomnia.

The sleep-school at Bjørgvin District Psychiatric Hospital (DPS) is an already established treatment since 2017. The insomnia-group gets together every other Monday from noon until 2 pm. The group is open, which means that participants start at different dates and meet people in the group that might be at the end of their CBTi treatment. Participants are patients at the general psychiatric outpatient clinic at Bjørgvin DPS. Participant have been referred to the sleep-team by their psychologist or doctor. In this RCT the investigators will carry on the same structure for the group for participants that are recruited to the RCT.

All participants have an individual consultation before joining the group where the focus is on eligibility to participate in the group-based treatment, diagnostic evaluation, receive a standardized education on sleep-regulation and sleep hygiene advice and receive a date to start the group-based CBTi treatment. In a randomized manner, they will be allocated to the sleep-school group and start the treatment on the next possible date or to a 8 week wait-list and receive a date the treatment starts. All eligible participants will be informed that there may be a waitlist and receive a start-date without being informed that thay are in a waitlist group or not a waitlist group. All participants will be treated as usual (TAU) for their psychiatric problems parallel to either sleep-school or waitlist. Participants that start sleep-school as soon as possible, are also allocated to a) ordinary group-based CBTi 8 weeks or b) group-based CBTi 8 weeks and bb-glasses. All participant will be followed up after 12 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients referred to the sleep-school at Bjørgvin DPS psychiatric hospital
  • Patients fulfilling the Diagnostic Manual for Mental Disorders (DSM-V) criteria for insomnia comorbid to moderate to severe psychiatric illness (confirmed F-diagnosis based on the International Statistical Classification of Diseases and Related Health Problems (ICD-11) diagnostic system that are used in Norway in addition to insomnia and/or scores of ≥19 on BDI and/or scores of ≥16 on BAI at the time of referral to the sleep school)

Exclusion criteria

  • Nightwork
  • Patients that do not fulfil the DSM-V criteria for insomnia comorbid to moderate to severe psychiatric illness (confirmed F-diagnosis based on the ICD-10 diagnostic system that are used in Norway in addition to insomnia and/or scores of ≥19 on BDI and/or scores of ≥16 on BAI at the time of referral to the sleep school)

Treatment and study plan

Group-based cognitive behavioral therapy for insomnia

Behavioral

Sleep education, sleep restriction, stimulus control, cognitive restructuring, relaxation techniques

Other names: Group - CBTi

Group-based cognitive behavioral therapy for insomnia and additive bb-glasses

Behavioral

Sleep education, sleep restriction, stimulus control, cognitive restructuring, relaxation techniques, bb-glasses worn from 3 hrs before bedtime.

Other names: Group - CBTi & bb-glasses

8-week wait list for sleep-school

Other

Treatment as usual in a psychiatric outpatient clinic

Other names: Treatment as usual

Primary outcomes

  1. Insomnia symptoms

    Time frame: baseline, bi-weekly and post intervention after 8 weeks, follow-up after 12 months

    Measured by the questionnaires Insomnia severity Index (ISI) and Bergen Insomnia Scale (BIS). From sleep diaries; sleep onset latency (SOL), wake after sleep onset (WASO) and sleep efficiency (SE).

Secondary outcomes

  1. Changes in insomnia diagnosis

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    Measured by the Bergen Bergen Insomnia Scale (BIS). The BIS measure subjective symptoms of insomnia during the previous week and give a total score (minimum 0, maximum 42; the higher the score, the worse severity of insomnia) and a clinical incidence of insomnia diagnosis-score (yes/no)

  2. Changes in insomnia severity

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    Measured by the Insomnia Severity Index (ISI). The ISI is a 7-item scale assessing the perceived severity of insomnia symptoms (initial, middle, terminal), the degree of satisfaction with sleep, interference with daytime functioning, noticeability of impairment, and concern caused by the sleep problems. The scale is Likert-type with 5 anchor points ranging from 0 to 4. The scale ranges from 0 to 28 and the higher the score, the more severe insomnia. The usual time frame for responding is the last 2 weeks.

  3. Changes in Time in bed (TIB)

    Time frame: baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months

    Measured by sleep diary; time from bed-time to rise time

  4. Changes in objective early morning awakening (EMA)

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number of average minutes early morning awakening.

  5. Changes in objective wake after sleep onset (WASO)

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number of average minutes awake after sleep onset.

  6. Changes in Early morning awakening (EMA)

    Time frame: baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months

    Measured by sleep diary; minutes awake before rise time

  7. Changes in objective time in bed (TIB)

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number in minutes of average time in bed.

  8. Changes in objective sleep efficiency (SE)

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number from 0-100% that gives average sleep efficiency.

  9. Changes in objective total sleep length/time asleep (TST),

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number in minutes of average total sleep time.

  10. Changes in Total sleep length/time asleep (TST)

    Time frame: baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months

    Measured by sleep diary: Time in bed minus time awake

  11. Changes in Sleep quality (SQ)

    Time frame: baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months

    Measured by sleep diary; subjective assesment of sleep quality on a scale from 1=very light to 5=very deep

  12. Changes in Daytime function (DF)

    Time frame: baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months

    Measured by sleep diary; subjective assesment of daytime function on a scale from 1=very good to 5=very poor

  13. Changes in objective sleep onset latency (SOL)

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number of minutes of average sleep onset latency.

  14. Changes in beliefs and attitudes about sleep

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    Measured by Dysfunctional Beliefs and Attitudes about Sleep (DBAS-16). The DBAS-16 measures the degree of dysfunctional beliefs about sleep with 16 items. It has 4 subscales (1) sleep-related worry and helplessness; 2) beliefs about sleep medications; 3) expectations about sleep need; and 4) beliefs about the consequences/effects of insomnia and 1 total scale score. The higher the score, the more dysfunctional beliefs about sleep.

  15. Changes in depression

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    Measured by Becks Depression Inventory -II (BDI-II). The higher the score, the more symptoms of depression

  16. Changes in anxiety

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    Measured by Becks Anxiety Inventory (BAI). The higher the score, the more symptoms of anxiety

  17. Changes in fatigue

    Time frame: baseline and post intervention after 8 weeks, and at follow-up after 12 months

    Measured by Chalder fatigue Scale (CFQ). The higher the score, the more fatigued

  18. Work status

    Time frame: baseline and post intervention after 8 weeks, and at follow-up after 12 months

    Status of employment/unemployment, percentage disability benefits received. Measured by Work and social adjustment scale (WSAS) and self-report.

  19. Well-being

    Time frame: baseline and post intervention after 8 weeks, and at follow-up after 12 months

    Measured by World Health Organization well-being scale (WHO-5). The higher the score, the higher well-being.

Other outcomes

  1. Changes in symptoms of inattention

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    Measured by the Adult attention deficit hyperactivity disorder (ADHD) Self-Rating Scale (ASRS). The scale contains the 18 symptoms of inattention, hyperactivity, and impulsivity defining ADHD according to the DSM-IV-TR and DSM-5. The severity of the symptoms are reported on a 5-point Likert-type scale (0-4 = never, rarely, sometimes, often, to very often), with a total range of 0-72. The higher the score, the more symptoms of inattention.

  2. Changes in vigilance

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    Measured by the Conners Continuous Performance (CPT) Test 3rd Edition™ (Conners CPT 3™)

  3. Changes in self reported emotion regulation ability

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    Measured by Difficulties in Emotion Regulation Scale (DERS) which is a 18-item self-report measure of six facets of emotion regulation. Items are rated on a scale of 1 ("almost never [0-10%]") to 5 ("almost always [91-100%]"). Higher scores suggest greater problems with emotion regulation.

  4. Changes in degree of experienced pain

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    Measured by a visual analogue scale (VAS Pain) ranging from 0 to 10. The higher the score, the worse the pain.

  5. Changes in symptoms of hypochondria

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    Measured by the The Whiteley Index (WI). The 14-item WI measures assess health anxiety on a likert-scale from 1="not at all" to "5=very much". The higher the score, the more severe health anxiety.

  6. Changes in executive functions

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    We will measure self-reported executive functions using the Behaviour Rating Inventory for Executive Functions Self-Report (BRIEF- SR)

  7. Changes in blood pressure

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    We will measure systolic and diastolic pressure by a digital blood pressure measurement machine.

  8. Changes in Heart rate variability (HRV)

    Time frame: baseline and post intervention after 8 weeks, follow-up after 12 months

    24 -hour HRV.

  9. Client Satisfaction

    Time frame: post intervention after 8 weeks

    Measured by the Client Satisfaction Questionnaire (CSQ8). The CSQ-8 is an 8-item questionnaire that measures patient satisfaction with health services, where the items are rated from 1 (very low satisfaction) to 4 (very high satisfaction). The total score ranges from 8 to 32, with higher scores indicating higher degrees of satisfaction.

  10. Changes in sleepiness

    Time frame: baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months

    Measured by the Epworth Sleepiness Scale (ESS). The ESS is an 8-item scale where the respondent grades the likelihood of falling asleep or dozing off in different daily situations. The responses are graded on a 4-point likert scale 0=no likelihodd to 3=very likely. A score of 11 or higher is considered an indication of excessive daytime sleepiness.

  11. Changes in immediate sleepiness

    Time frame: baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months

    Measured by the Karolinska Sleepiness Scale (KSS). The KSS measure subjective sleepiness at a specific time point (noon). The scale gives a number from 1-9 where 9 indicates "trouble staying awake" and is the worst outcome.

  12. Suicide attempts and admittances in psychiatric wards

    Time frame: baseline and post intervention after 8 weeks, and at follow-up after 12 months

    Whether or not suicide has been attempted, if applicable number og attempts and whether or nor the patient has been admitted to a psychitaric ward (voluntary/forced)

Study contacts

Contact information is provided by the study sponsor or research team.

Ane Wilhelmsen-Langeland, PhD

CONTACT

[email protected]

+47 55957000

Berge Osnes, PhD

CONTACT

[email protected]

+47 55957000

Sponsors and collaborators

Lead sponsor

Haukeland University Hospital

Other

Collaborators

  • University of Bergen

Registry information

Official study title

Sleep in Psychiatric Care: A Transdiagnostic Group-based Sleep-school as Treatment for Comorbid Insomnia

Acronym: SIP

Important dates

Study start
2021
Primary completion
2026
Study completion
2027
First posted
Jul 9, 2020
Registry last updated
Jun 18, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.